Friday, August 1, 2025
NewsWave
No Result
View All Result
  • Home
  • World
  • USA
  • Business
  • Sports
  • Entertainment
  • Technology
Login
  • Home
  • World
  • USA
  • Business
  • Sports
  • Entertainment
  • Technology
Login
No Result
View All Result
Login
NewsWave
No Result
View All Result
Home Business

Top line can grow to Rs 2.5 trn in 5-10 yrs if executed well: Zepto CEO | Company News

6 July 2024
in Business
0
Top line can grow to Rs 2.5 trn in 5-10 yrs if executed well: Zepto CEO | Company News
Share on FacebookShare on Twitter
How does this make you feel?



Zepto CEO believes that the top line of the company can grow to Rs 2.5 trillion within the next 5-10 years if the execution is done well. The CEO is confident in the company’s ability to achieve this ambitious goal with strategic planning and efficient operations. This news is a positive outlook for the company’s future growth and success.

Source link

🪄 Creating a simple explanation...

Tags: CEOcompanyexecutedgrowlineNewstoptrnYrsZepto
Previous Post

Wallabies down Wales in Joe Schmidt’s first Test as coach, while Wallaroos thrash Fijiana 64-5

Next Post

New UK Prime Minister Starmer assembles Cabinet for the first meeting: ‘Now we get to work’

Related Posts

Peoples Financial (PFIS) Q2 EPS Up 265%
Business

Peoples Financial (PFIS) Q2 EPS Up 265%

by My News Wave
1 August 2025
0

Peoples Financial Services (NASDAQ:PFIS), a Pennsylvania community bank holding company, reported Q2 2025 earnings of $1.68 per share, exceeding the $1.47 forecast and significantly up from $0.46 a year prior. The bank saw net interest income more than double year-over-year, reflecting successful merger integration and improved efficiency ratios and asset quality. Want More Context? 🔎

Read more
Sirius XM (SIRI) Q2 Revenue Rises 2%
Business

Sirius XM (SIRI) Q2 Revenue Rises 2%

by My News Wave
1 August 2025
0

Sirius XM (NASDAQ:SIRI) reported Q2 2025 earnings on July 31, revealing GAAP earnings per share of $0.57, missing expectations by $0.20 due to decreased net income and higher legal and restructuring costs. Despite showcasing strong free cash flow and innovation in content, profitability pressures persist; management remains optimistic about the full-year outlook amid challenging subscriber trends. Want More Context? 🔎

Read more
Is an XRP Pullback on the Horizon? Here's What Investors Need to Know.
Business

Is an XRP Pullback on the Horizon? Here's What Investors Need to Know.

by My News Wave
1 August 2025
0

XRP (CRYPTO: XRP) experienced a notable 43% gain over 30 days ending July 29, but seasoned investors anticipate a pullback is inevitable, questioning its timing and depth. Key factors may soon trigger this correction, though past dips in XRP often appear as opportunities rather than failures, suggesting underlying strength in its long-term investment thesis. Want More Context? 🔎

Read more
Seacor (SMHI) Q2 Revenue Drops 13%
Business

Seacor (SMHI) Q2 Revenue Drops 13%

by My News Wave
31 July 2025
0

Seacor Marine (NYSE:SMHI) reported Q2 2025 results on July 30, revealing GAAP revenue of $60.8 million, missing expectations by 12.3%, while its GAAP loss per share of $(0.26) was slightly better than anticipated. The company's operating revenue declined by 13.0% year-over-year due to high repair expenses, although ongoing fleet modernization efforts showed some sequential improvements. Want More Context? 🔎

Read more
Why Did Micron Stock Drop Today?
Business

Why Did Micron Stock Drop Today?

by My News Wave
31 July 2025
0

Shares of Micron Technology (NASDAQ: MU) fell 5.2% on Thursday morning, primarily due to issues attributed to Samsung, rather than any specific actions by Micron itself. The decline highlights the interconnected nature of the semiconductor industry and how external factors can significantly impact stock performance. Want More Context? 🔎

Read more
Lenz (LENZ) Q2 Revenue Jumps 604%
Business

Lenz (LENZ) Q2 Revenue Jumps 604%

by My News Wave
31 July 2025
0

Lenz Therapeutics (NASDAQ:LENZ) reported second quarter 2025 results on July 30, revealing $5.0 million in GAAP revenue from licensing milestones, significantly surpassing analyst expectations. Despite a deeper net loss due to increased spending, the company made strides in its commercial plans ahead of an important FDA decision for its lead product, LNZ100, aimed at treating presbyopia. Want More Context? 🔎

Read more
NewsWave

News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.

CATEGORIES

  • Africa
  • Asia Pacific
  • Australia
  • Business
  • Canada
  • Entertainment
  • Europe
  • India
  • Middle East
  • New Zealand
  • Sports
  • Technology
  • UK
  • USA
  • World

LATEST NEWS STORIES

  • Jeremy Strong Eyed To Play Mark Zuckerberg In Aaron Sorkin’s THE SOCIAL NETWORK PART II
  • Why has Washington sanctioned the Palestinian leadership? | Israel-Palestine conflict News
  • Reddit puts its plans for paid subreddits on hold
  • About Us
  • Disclaimer
  • Privacy Policy
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • USA
  • Business
  • Sports
  • Entertainment
  • Technology

Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In